ADALTA LIMITED

ASX: 1AD

Sector: Sector:Health Care
Industry group: Industry:Pharmaceuticals, Biotechnology & Life Sciences

1AD News & Analysis

1ADHealth CareCompany Update2 Sept 20262 September 2026· 2 min read

AdAlta (ASX: 1AD) Wins China Special Access for CAR-T Therapy

AdAlta partner SHcell can provide BZDS1901 to eligible advanced mesothelioma patients in Hainan. The scheme will generate real-world data for AdAlta’s EW-001 program.

1ADHealth CareCompany Update10 Aug 202610 August 2026· 2 min read

AdAlta (ASX: 1AD) Reports Continued Survival in EW-001 Study

All five EW-001 patients still under follow-up in March remained alive and on study in July. Higher-dose data support AdAlta’s planned Australian Phase 1 trial.

Latest 1AD ASX Announcements

5 Oct 2026 · 8:24 amCompany Update
EW-001 JDC milestone approvals
5 Oct 20268:24 amEW-001 JDC milestone approvalsCompany Update
1 Oct 2026 · 8:42 amCompany Update
China Representative Office opens
1 Oct 20268:42 amChina Representative Office opensCompany Update
30 Sept 2026 · 9:45 amMeetings & Governance
Date of AGM & Closing Date for Director Nominations
30 Sept 20269:45 amDate of AGM & Closing Date for Director NominationsMeetings & Governance
23 Sept 2026 · 8:17 amCompany Update
US FDA grants EW-001 pre-IND meeting
23 Sept 20268:17 amUS FDA grants EW-001 pre-IND meetingCompany Update
18 Sept 2026 · 9:52 amCompany Update
Oribiotech deal validates AdAlta manufacturing strategy
18 Sept 20269:52 amOribiotech deal validates AdAlta manufacturing strategyCompany Update
15 Sept 2026 · 8:22 amCompany Administration
CAR-TCR Summit poster
15 Sept 20268:22 amCAR-TCR Summit posterCompany Administration
10 Sept 2026 · 9:49 amPresentations
Bilingual BIOSeedin Investor Presentation
10 Sept 20269:49 amBilingual BIOSeedin Investor PresentationPresentations
2 Sept 2026 · 9:30 amCompany Update
BZDS1901 special access scheme launch in China
2 Sept 20269:30 amBZDS1901 special access scheme launch in ChinaCompany Update
21 Aug 2026 · 5:00 pmCompany Administration
Appendix 4G and Corporate Governance Statement
21 Aug 20265:00 pmAppendix 4G and Corporate Governance StatementCompany Administration
21 Aug 2026 · 4:58 pmFinancial Results
Annual Report to shareholders
21 Aug 20264:58 pmAnnual Report to shareholdersFinancial Results
21 Aug 2026 · 4:54 pmFinancial Results
Preliminary Final Report
21 Aug 20264:54 pmPreliminary Final ReportFinancial Results
13 Aug 2026 · 9:21 amPresentations
Investor presentation
13 Aug 20269:21 amInvestor presentationPresentations
10 Aug 2026 · 9:18 amCompany Update
EW-001 IIT study overall survival update
10 Aug 20269:18 amEW-001 IIT study overall survival updateCompany Update
5 Aug 2026 · 8:26 amCompany Update
2 year survival milestone for EW-001 patient
5 Aug 20268:26 am2 year survival milestone for EW-001 patientCompany Update
29 July 2026 · 9:23 amQuarterly Reports
Quarterly Appendix 4C and Activities Report
29 July 20269:23 amQuarterly Appendix 4C and Activities ReportQuarterly Reports

View complete 1AD announcement history →

ADALTA LIMITED

1AD Share Price

1AD News & Analysis

AdAlta (ASX: 1AD) Wins China Special Access for CAR-T Therapy

AdAlta (ASX: 1AD) Reports Continued Survival in EW-001 Study

Latest 1AD ASX Announcements